Skip to main content
NCBI home page
Molecular Biology of the Cell logoLink to Molecular Biology of the Cell
. 1997 Aug;8(8):1619–1631. doi: 10.1091/mbc.8.8.1619

The carboxyl-terminal valine residues of proTGF alpha are required for its efficient maturation and intracellular routing.

G P Briley 1, M A Hissong 1, M L Chiu 1, D C Lee 1
PMCID: PMC276180  PMID: 9285829

Abstract

Soluble forms of transforming growth factor-alpha (TGF alpha) are derived by proteolytic processing of an integral membrane glycoprotein precursor (pro TGF alpha). Previous studies indicated that phorbol ester-induced cleavage of pro TGF alpha in CHO cells is dependent on the presence of a valine residue located at the carboxyl terminus of the precursor's cytoplasmic domain. We reassessed this requirement with epitope-tagged constructs introduced into transformed rat liver epithelial cells that normally express and process TGF alpha. We found that pro TGF alpha mutants lacking the terminal valine residues showed greatly reduced maturation to the fully glycosylated form. Additionally, they were present at substantially reduced levels on the cell surface and, instead, accumulated in the endoplasmic reticulum. Consistent with these results, enzyme-linked immunosorbent assay (ELISA) and Western blot analyses revealed little or no soluble TGF alpha in medium conditioned by cells expressing the mutant constructs. Finally, a truncated pro TGF alpha mutant lacking most of the cytoplasmic domain but retaining a carboxyl-terminal valine was processed and cleaved in a near-normal manner. These results, some of which were reproduced in CHO cells, indicate that the predominant effect of the carboxyl-terminal valines is to ensure normal maturation and routing of the precursor.

Full text

PDF
1619

Images in this article

1623Image
on p.1623
1625Image
on p.1625
1626Image
on p.1626
1626Image
on p.1626
1627Image
on p.1627
1628Image
on p.1628
1629Image
on p.1629

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Anklesaria P., Teixidó J., Laiho M., Pierce J. H., Greenberger J. S., Massagué J. Cell-cell adhesion mediated by binding of membrane-anchored transforming growth factor alpha to epidermal growth factor receptors promotes cell proliferation. Proc Natl Acad Sci U S A. 1990 May;87(9):3289–3293. doi: 10.1073/pnas.87.9.3289. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Arribas J., Massagué J. Transforming growth factor-alpha and beta-amyloid precursor protein share a secretory mechanism. J Cell Biol. 1995 Feb;128(3):433–441. doi: 10.1083/jcb.128.3.433. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Berkowitz E. A., Hissong M. A., Lee D. C. Transcriptional and post-transcriptional induction of the TGFalpha gene in transformed rat liver epithelial cells. Oncogene. 1996 May 2;12(9):1991–2002. [PubMed] [Google Scholar]
  4. Blasband A. J., Gilligan D. M., Winchell L. F., Wong S. T., Luetteke N. C., Rogers K. T., Lee D. C. Expression of the TGF alpha integral membrane precursor induces transformation of NRK cells. Oncogene. 1990 Aug;5(8):1213–1221. [PubMed] [Google Scholar]
  5. Bosenberg M. W., Pandiella A., Massagué J. Activated release of membrane-anchored TGF-alpha in the absence of cytosol. J Cell Biol. 1993 Jul;122(1):95–101. doi: 10.1083/jcb.122.1.95. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Bosenberg M. W., Pandiella A., Massagué J. The cytoplasmic carboxy-terminal amino acid specifies cleavage of membrane TGF alpha into soluble growth factor. Cell. 1992 Dec 24;71(7):1157–1165. doi: 10.1016/s0092-8674(05)80064-9. [DOI] [PubMed] [Google Scholar]
  7. Brachmann R., Lindquist P. B., Nagashima M., Kohr W., Lipari T., Napier M., Derynck R. Transmembrane TGF-alpha precursors activate EGF/TGF-alpha receptors. Cell. 1989 Feb 24;56(4):691–700. doi: 10.1016/0092-8674(89)90591-6. [DOI] [PubMed] [Google Scholar]
  8. Brannan C. I., Bedell M. A., Resnick J. L., Eppig J. J., Handel M. A., Williams D. E., Lyman S. D., Donovan P. J., Jenkins N. A., Copeland N. G. Developmental abnormalities in Steel17H mice result from a splicing defect in the steel factor cytoplasmic tail. Genes Dev. 1992 Oct;6(10):1832–1842. doi: 10.1101/gad.6.10.1832. [DOI] [PubMed] [Google Scholar]
  9. Brannan C. I., Lyman S. D., Williams D. E., Eisenman J., Anderson D. M., Cosman D., Bedell M. A., Jenkins N. A., Copeland N. G. Steel-Dickie mutation encodes a c-kit ligand lacking transmembrane and cytoplasmic domains. Proc Natl Acad Sci U S A. 1991 Jun 1;88(11):4671–4674. doi: 10.1073/pnas.88.11.4671. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Bringman T. S., Lindquist P. B., Derynck R. Different transforming growth factor-alpha species are derived from a glycosylated and palmitoylated transmembrane precursor. Cell. 1987 Feb 13;48(3):429–440. doi: 10.1016/0092-8674(87)90194-2. [DOI] [PubMed] [Google Scholar]
  11. Brodbeck R. M., Brown J. L. Secretion of alpha-1-proteinase inhibitor requires an almost full length molecule. J Biol Chem. 1992 Jan 5;267(1):294–297. [PubMed] [Google Scholar]
  12. Cappelluti E., Strom S. C., Harris R. B. Potential role of two novel elastase-like enzymes in processing pro-transforming growth factor-alpha. Biochemistry. 1993 Jan 19;32(2):551–560. doi: 10.1021/bi00053a021. [DOI] [PubMed] [Google Scholar]
  13. Cheng H. J., Flanagan J. G. Transmembrane kit ligand cleavage does not require a signal in the cytoplasmic domain and occurs at a site dependent on spacing from the membrane. Mol Biol Cell. 1994 Sep;5(9):943–953. doi: 10.1091/mbc.5.9.943. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Collier E., Carpentier J. L., Beitz L., Carol H., Taylor S. I., Gorden P. Specific glycosylation site mutations of the insulin receptor alpha subunit impair intracellular transport. Biochemistry. 1993 Aug 3;32(30):7818–7823. doi: 10.1021/bi00081a029. [DOI] [PubMed] [Google Scholar]
  15. Davis S., Gale N. W., Aldrich T. H., Maisonpierre P. C., Lhotak V., Pawson T., Goldfarb M., Yancopoulos G. D. Ligands for EPH-related receptor tyrosine kinases that require membrane attachment or clustering for activity. Science. 1994 Nov 4;266(5186):816–819. doi: 10.1126/science.7973638. [DOI] [PubMed] [Google Scholar]
  16. Defeo-Jones D., Tai J. Y., Wegrzyn R. J., Vuocolo G. A., Baker A. E., Payne L. S., Garsky V. M., Oliff A., Riemen M. W. Structure-function analysis of synthetic and recombinant derivatives of transforming growth factor alpha. Mol Cell Biol. 1988 Aug;8(8):2999–3007. doi: 10.1128/mcb.8.8.2999. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Derynck R., Roberts A. B., Winkler M. E., Chen E. Y., Goeddel D. V. Human transforming growth factor-alpha: precursor structure and expression in E. coli. Cell. 1984 Aug;38(1):287–297. doi: 10.1016/0092-8674(84)90550-6. [DOI] [PubMed] [Google Scholar]
  18. Dobashi Y., Stern D. F. Membrane-anchored forms of EGF stimulate focus formation and intercellular communication. Oncogene. 1991 Jul;6(7):1151–1159. [PubMed] [Google Scholar]
  19. Doyle C., Sambrook J., Gething M. J. Analysis of progressive deletions of the transmembrane and cytoplasmic domains of influenza hemagglutinin. J Cell Biol. 1986 Oct;103(4):1193–1204. doi: 10.1083/jcb.103.4.1193. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Ehlers M. R., Riordan J. F. Membrane proteins with soluble counterparts: role of proteolysis in the release of transmembrane proteins. Biochemistry. 1991 Oct 22;30(42):10065–10074. doi: 10.1021/bi00106a001. [DOI] [PubMed] [Google Scholar]
  21. Flanagan J. G., Chan D. C., Leder P. Transmembrane form of the kit ligand growth factor is determined by alternative splicing and is missing in the Sld mutant. Cell. 1991 Mar 8;64(5):1025–1035. doi: 10.1016/0092-8674(91)90326-t. [DOI] [PubMed] [Google Scholar]
  22. Gentry L. E., Twardzik D. R., Lim G. J., Ranchalis J. E., Lee D. C. Expression and characterization of transforming growth factor alpha precursor protein in transfected mammalian cells. Mol Cell Biol. 1987 May;7(5):1585–1591. doi: 10.1128/mcb.7.5.1585. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Gray A., Dull T. J., Ullrich A. Nucleotide sequence of epidermal growth factor cDNA predicts a 128,000-molecular weight protein precursor. Nature. 1983 Jun 23;303(5919):722–725. doi: 10.1038/303722a0. [DOI] [PubMed] [Google Scholar]
  24. Green J. M., Gu L., Ifkovits C., Kaumaya P. T., Conrad S., Pierce S. K. Generation and characterization of monoclonal antibodies specific for members of the mammalian 70-kDa heat shock protein family. Hybridoma. 1995 Aug;14(4):347–354. doi: 10.1089/hyb.1995.14.347. [DOI] [PubMed] [Google Scholar]
  25. Harano T., Mizuno K. Phorbol ester-induced activation of a membrane-bound candidate pro-transforming growth factor-alpha processing enzyme. J Biol Chem. 1994 Aug 12;269(32):20305–20311. [PubMed] [Google Scholar]
  26. Hart A. C., Krämer H., Van Vactor D. L., Jr, Paidhungat M., Zipursky S. L. Induction of cell fate in the Drosophila retina: the bride of sevenless protein is predicted to contain a large extracellular domain and seven transmembrane segments. Genes Dev. 1990 Nov;4(11):1835–1847. doi: 10.1101/gad.4.11.1835. [DOI] [PubMed] [Google Scholar]
  27. Holland S. J., Gale N. W., Mbamalu G., Yancopoulos G. D., Henkemeyer M., Pawson T. Bidirectional signalling through the EPH-family receptor Nuk and its transmembrane ligands. Nature. 1996 Oct 24;383(6602):722–725. doi: 10.1038/383722a0. [DOI] [PubMed] [Google Scholar]
  28. Huang E. J., Nocka K. H., Buck J., Besmer P. Differential expression and processing of two cell associated forms of the kit-ligand: KL-1 and KL-2. Mol Biol Cell. 1992 Mar;3(3):349–362. doi: 10.1091/mbc.3.3.349. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Ignotz R. A., Kelly B., Davis R. J., Massagué J. Biologically active precursor for transforming growth factor type alpha, released by retrovirally transformed cells. Proc Natl Acad Sci U S A. 1986 Sep;83(17):6307–6311. doi: 10.1073/pnas.83.17.6307. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Kaneko Y., Takenawa J., Yoshida O., Fujita K., Sugimoto K., Nakayama H., Fujita J. Adhesion of mouse mast cells to fibroblasts: adverse effects of steel (Sl) mutation. J Cell Physiol. 1991 May;147(2):224–230. doi: 10.1002/jcp.1041470206. [DOI] [PubMed] [Google Scholar]
  31. Kawasaki E. S., Ladner M. B., Wang A. M., Van Arsdell J., Warren M. K., Coyne M. Y., Schweickart V. L., Lee M. T., Wilson K. J., Boosman A. Molecular cloning of a complementary DNA encoding human macrophage-specific colony-stimulating factor (CSF-1). Science. 1985 Oct 18;230(4723):291–296. doi: 10.1126/science.2996129. [DOI] [PubMed] [Google Scholar]
  32. Kobrin M. S., Samsoondar J., Kudlow J. E. Alpha-transforming growth factor secreted by untransformed bovine anterior pituitary cells in culture. II. Identification using a sequence-specific monoclonal antibody. J Biol Chem. 1986 Nov 5;261(31):14414–14419. [PubMed] [Google Scholar]
  33. Kornfeld R., Kornfeld S. Assembly of asparagine-linked oligosaccharides. Annu Rev Biochem. 1985;54:631–664. doi: 10.1146/annurev.bi.54.070185.003215. [DOI] [PubMed] [Google Scholar]
  34. Koshimizu U., Tsujimura T., Isozaki K., Nomura S., Furitsu T., Kanakura Y., Kitamura Y., Nishimune Y. Wn mutation of c-kit receptor affects its post-translational processing and extracellular expression. Oncogene. 1994 Jan;9(1):157–162. [PubMed] [Google Scholar]
  35. Lee D. C., Fenton S. E., Berkowitz E. A., Hissong M. A. Transforming growth factor alpha: expression, regulation, and biological activities. Pharmacol Rev. 1995 Mar;47(1):51–85. [PubMed] [Google Scholar]
  36. Lee D. C., Rose T. M., Webb N. R., Todaro G. J. Cloning and sequence analysis of a cDNA for rat transforming growth factor-alpha. Nature. 1985 Feb 7;313(6002):489–491. doi: 10.1038/313489a0. [DOI] [PubMed] [Google Scholar]
  37. Lehrman M. A., Goldstein J. L., Brown M. S., Russell D. W., Schneider W. J. Internalization-defective LDL receptors produced by genes with nonsense and frameshift mutations that truncate the cytoplasmic domain. Cell. 1985 Jul;41(3):735–743. doi: 10.1016/s0092-8674(85)80054-4. [DOI] [PubMed] [Google Scholar]
  38. Linsley P. S., Hargreaves W. R., Twardzik D. R., Todaro G. J. Detection of larger polypeptides structurally and functionally related to type I transforming growth factor. Proc Natl Acad Sci U S A. 1985 Jan;82(2):356–360. doi: 10.1073/pnas.82.2.356. [DOI] [PMC free article] [PubMed] [Google Scholar]
  39. Lodish H. F. Transport of secretory and membrane glycoproteins from the rough endoplasmic reticulum to the Golgi. A rate-limiting step in protein maturation and secretion. J Biol Chem. 1988 Feb 15;263(5):2107–2110. [PubMed] [Google Scholar]
  40. Loebermann H., Tokuoka R., Deisenhofer J., Huber R. Human alpha 1-proteinase inhibitor. Crystal structure analysis of two crystal modifications, molecular model and preliminary analysis of the implications for function. J Mol Biol. 1984 Aug 15;177(3):531–557. [PubMed] [Google Scholar]
  41. Loo T. W., Clarke D. M. Functional consequences of glycine mutations in the predicted cytoplasmic loops of P-glycoprotein. J Biol Chem. 1994 Mar 11;269(10):7243–7248. [PubMed] [Google Scholar]
  42. Luetteke N. C., Michalopoulos G. K., Teixidó J., Gilmore R., Massagué J., Lee D. C. Characterization of high molecular weight transforming growth factor alpha produced by rat hepatocellular carcinoma cells. Biochemistry. 1988 Aug 23;27(17):6487–6494. doi: 10.1021/bi00417a043. [DOI] [PubMed] [Google Scholar]
  43. Marquardt H., Hunkapiller M. W., Hood L. E., Twardzik D. R., De Larco J. E., Stephenson J. R., Todaro G. J. Transforming growth factors produced by retrovirus-transformed rodent fibroblasts and human melanoma cells: amino acid sequence homology with epidermal growth factor. Proc Natl Acad Sci U S A. 1983 Aug;80(15):4684–4688. doi: 10.1073/pnas.80.15.4684. [DOI] [PMC free article] [PubMed] [Google Scholar]
  44. Massagué J., Pandiella A. Membrane-anchored growth factors. Annu Rev Biochem. 1993;62:515–541. doi: 10.1146/annurev.bi.62.070193.002503. [DOI] [PubMed] [Google Scholar]
  45. Miura Y., Kambe F., Yamamori I., Mori Y., Tani Y., Murata Y., Oiso Y., Seo H. A truncated thyroxine-binding globulin due to a frameshift mutation is retained within the rough endoplasmic reticulum: a possible mechanism of complete thyroxine-binding globulin deficiency in Japanese. J Clin Endocrinol Metab. 1994 Feb;78(2):283–287. doi: 10.1210/jcem.78.2.8106612. [DOI] [PubMed] [Google Scholar]
  46. Mroczkowski B., Reich M., Chen K., Bell G. I., Cohen S. Recombinant human epidermal growth factor precursor is a glycosylated membrane protein with biological activity. Mol Cell Biol. 1989 Jul;9(7):2771–2778. doi: 10.1128/mcb.9.7.2771. [DOI] [PMC free article] [PubMed] [Google Scholar]
  47. Mueller S. G., Paterson A. J., Kudlow J. E. Transforming growth factor alpha in arterioles: cell surface processing of its precursor by elastases. Mol Cell Biol. 1990 Sep;10(9):4596–4602. doi: 10.1128/mcb.10.9.4596. [DOI] [PMC free article] [PubMed] [Google Scholar]
  48. Pandiella A., Bosenberg M. W., Huang E. J., Besmer P., Massagué J. Cleavage of membrane-anchored growth factors involves distinct protease activities regulated through common mechanisms. J Biol Chem. 1992 Nov 25;267(33):24028–24033. [PubMed] [Google Scholar]
  49. Pandiella A., Massagué J. Cleavage of the membrane precursor for transforming growth factor alpha is a regulated process. Proc Natl Acad Sci U S A. 1991 Mar 1;88(5):1726–1730. doi: 10.1073/pnas.88.5.1726. [DOI] [PMC free article] [PubMed] [Google Scholar]
  50. Pandiella A., Massagué J. Multiple signals activate cleavage of the membrane transforming growth factor-alpha precursor. J Biol Chem. 1991 Mar 25;266(9):5769–5773. [PubMed] [Google Scholar]
  51. Perez C., Albert I., DeFay K., Zachariades N., Gooding L., Kriegler M. A nonsecretable cell surface mutant of tumor necrosis factor (TNF) kills by cell-to-cell contact. Cell. 1990 Oct 19;63(2):251–258. doi: 10.1016/0092-8674(90)90158-b. [DOI] [PubMed] [Google Scholar]
  52. Pfeffer S. R., Rothman J. E. Biosynthetic protein transport and sorting by the endoplasmic reticulum and Golgi. Annu Rev Biochem. 1987;56:829–852. doi: 10.1146/annurev.bi.56.070187.004145. [DOI] [PubMed] [Google Scholar]
  53. Pfeffer S., Ullrich A. Epidermal growth factor. Is the precursor a receptor? Nature. 1985 Jan 17;313(5999):184–184. doi: 10.1038/313184a0. [DOI] [PubMed] [Google Scholar]
  54. Sandgren E. P., Luetteke N. C., Palmiter R. D., Brinster R. L., Lee D. C. Overexpression of TGF alpha in transgenic mice: induction of epithelial hyperplasia, pancreatic metaplasia, and carcinoma of the breast. Cell. 1990 Jun 15;61(6):1121–1135. doi: 10.1016/0092-8674(90)90075-p. [DOI] [PubMed] [Google Scholar]
  55. Scott J., Urdea M., Quiroga M., Sanchez-Pescador R., Fong N., Selby M., Rutter W. J., Bell G. I. Structure of a mouse submaxillary messenger RNA encoding epidermal growth factor and seven related proteins. Science. 1983 Jul 15;221(4607):236–240. doi: 10.1126/science.6602382. [DOI] [PubMed] [Google Scholar]
  56. Shum L., Reeves S. A., Kuo A. C., Fromer E. S., Derynck R. Association of the transmembrane TGF-alpha precursor with a protein kinase complex. J Cell Biol. 1994 May;125(4):903–916. doi: 10.1083/jcb.125.4.903. [DOI] [PMC free article] [PubMed] [Google Scholar]
  57. Shum L., Turck C. W., Derynck R. Cysteines 153 and 154 of transmembrane transforming growth factor-alpha are palmitoylated and mediate cytoplasmic protein association. J Biol Chem. 1996 Nov 8;271(45):28502–28508. doi: 10.1074/jbc.271.45.28502. [DOI] [PubMed] [Google Scholar]
  58. Stein J., Rettenmier C. W. Proteolytic processing of a plasma membrane-bound precursor to human macrophage colony-stimulating factor (CSF-1) is accelerated by phorbol ester. Oncogene. 1991 Apr;6(4):601–605. [PubMed] [Google Scholar]
  59. Teixido J., Wong S. T., Lee D. C., Massagué J. Generation of transforming growth factor-alpha from the cell surface by an O-glycosylation-independent multistep process. J Biol Chem. 1990 Apr 15;265(11):6410–6415. [PubMed] [Google Scholar]
  60. Teixidó J., Massagué J. Structural properties of a soluble bioactive precursor for transforming growth factor-alpha. J Biol Chem. 1988 Mar 15;263(8):3924–3929. [PubMed] [Google Scholar]
  61. Traverse S., Gomez N., Paterson H., Marshall C., Cohen P. Sustained activation of the mitogen-activated protein (MAP) kinase cascade may be required for differentiation of PC12 cells. Comparison of the effects of nerve growth factor and epidermal growth factor. Biochem J. 1992 Dec 1;288(Pt 2):351–355. doi: 10.1042/bj2880351. [DOI] [PMC free article] [PubMed] [Google Scholar]
  62. Wong S. T., Winchell L. F., McCune B. K., Earp H. S., Teixidó J., Massagué J., Herman B., Lee D. C. The TGF-alpha precursor expressed on the cell surface binds to the EGF receptor on adjacent cells, leading to signal transduction. Cell. 1989 Feb 10;56(3):495–506. doi: 10.1016/0092-8674(89)90252-3. [DOI] [PubMed] [Google Scholar]

Articles from Molecular Biology of the Cell are provided here courtesy of American Society for Cell Biology

RESOURCES